Vivos Therapeutics Inc (VVOS)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$0.19+6.76%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · VVOS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 20.9 | 17.4 | 15.0 | 13.8 | 16.0 | 16.9 | 13.1 |
| Cost of Revenues | — | 6.9 | 6.0 | 0.2 | 0.2 | 0.4 | 0.1 |
| Gross Profit | 12.9 | 10.5 | 9.0 | 8.3 | 10.0 | 12.6 | 10.4 |
| Operating Expenses & Income | |||||||
| R&D Expenses | — | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | — |
| Operating Income | (22.6) | (19.9) | (11.2) | (17.3) | (25.0) | (20.4) | (12.0) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 1.4 | — | — | — | 0.0 | 0.1 |
| Asset Writedown | — | — | — | — | — | 0.9 | — |
| EBT, Incl. Unusual Items | (25.6) | (21.2) | (11.1) | (13.6) | (23.8) | (20.3) | (12.1) |
| Net Income | |||||||
| Minority Interest | — | (0.1) | — | — | — | — | — |
| Net Income | (25.5) | (21.2) | (11.1) | (13.6) | (23.8) | (20.3) | (12.1) |
| Per Share | |||||||
| Basic EPS | (1.44) | (2.07) | (2.22) | (11.14) | (25.90) | (0.96) | — |
| Diluted EPS | (1.44) | (2.07) | (2.22) | (11.14) | (25.90) | — | — |
| Revenue per Share | 1.18 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 17.7 | 10.3 | 5.0 | 1.2 | 0.9 | 21,233.5 | — |
| Diluted Weighted Avg Shares | 17.7 | 10.3 | 5.0 | 1.2 | 0.9 | — | — |
| Supplemental | |||||||
| EBITDA | — | (18.6) | (10.6) | (16.7) | (24.4) | (19.6) | (11.3) |
| EBIT | (22.6) | (19.9) | (11.2) | (17.3) | (25.0) | (20.4) | (12.0) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.